Vera N Gledacheva

Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.

18 publications 2020 – 2026 ORCID

What does Vera N Gledacheva research?

Vera N Gledacheva studies various natural extracts, especially from microalgae and plants like Moringa oleifera, to find out how they can benefit health. She investigates the specific compounds in these samples and how their quality, such as particle size or amino acid content, influences their effectiveness. Her research is aimed at finding better nutritional options for individuals dealing with digestive and metabolic issues, as well as offering natural remedies for inflammation and infections.

Key findings

  • The Indian microalgae powder showed stronger anti-inflammatory effects and improved stomach muscle contraction compared to the UK sample, making it more effective for digestive health.
  • Moringa oleifera leaf extracts from India contained twice the amount of amino acids and organic acids compared to other samples, indicating a richer nutritional profile.
  • The 50% ethanol extract of Moringa demonstrated antioxidant properties stronger than a common anti-inflammatory drug and increased muscle contractions in lab tests by up to 134%.

Frequently asked questions

Does Dr. Gledacheva study digestive health?
Yes, she focuses on how natural substances can improve digestive health.
What natural treatments has Dr. Gledacheva researched?
She has researched microalgae and Moringa oleifera extracts for their anti-inflammatory and antioxidant properties.
Is Dr. Gledacheva's work relevant to patients with inflammation?
Yes, her studies look into natural remedies that can help reduce inflammation and improve health.

Publications in plain English

Biogenic Synthesis, Structural Characterization, and Biological Evaluation of Nanoparticles Derived fromEthanolic Extract.

2026

Nanomaterials (Basel, Switzerland)

Ivanova A, Todorova M, Petrov D, Gledacheva V, Stefanova I +11 more

Plain English
This study looked at creating silver nanoparticles from a specific type of microalga and evaluated how these nanoparticles affect the chemical makeup and health benefits of the algal extract. The researchers found that the silver nanoparticles were mostly round and small, measuring between 10 and 50 nanometers, and had strong antibacterial effects, especially against bacteria like Staphylococcus. Additionally, these nanoparticles altered muscle activity in gastric tissue, suggesting they might help with digestive issues and could be used in health products and treatments. Who this helps: This benefits patients with digestive problems and those seeking natural remedies for infections.

PubMed

as a Source of Bioactive Compounds-A Systematic Review.

2025

Pharmaceuticals (Basel, Switzerland)

Ivanova S, Ivanova A, Todorova M, Gledacheva V, Nikolova S

Plain English
This study reviewed research on a group of plants known for their potential health benefits, looking at 134 studies published from 1990 to 2025. The researchers found that certain chemicals in these plants, like thiophenes and terpenes, show promise in fighting inflammation, malaria, diabetes, cancer, and protecting the brain. These findings matter because they highlight a natural source that could lead to new treatments, although more testing is needed to ensure these compounds are safe and effective for medical use. Who this helps: This helps patients seeking alternative therapies and doctors looking for new treatment options.

PubMed

Fromto Nanomaterials: A Comparative Study of AgNPs Obtained from Two Extracts.

2025

Nanomaterials (Basel, Switzerland)

Ivanova A, Todorova M, Petrov D, Petkova Z, Teneva O +8 more

Plain English
This study looked at how silver nanoparticles (tiny particles of silver) can be made using two different sources: one from a bioreactor in Bulgaria and the other from a local health food store. The researchers found that the size and effectiveness of the particles varied, with the bioreactor source producing smaller particles (4-8 nanometers) and the store source producing larger ones (about 20 nanometers). The extracted particles showed good antibacterial properties and were effective at protecting proteins from heat damage. Who this helps: This research benefits patients who need better treatments for infections and inflammation.

PubMed

Silver Nanoparticles with Mebeverine in IBS Treatment: DFT Analysis, Spasmolytic, and Anti-Inflammatory Effects.

2025

Pharmaceutics

Stoyanova M, Milusheva M, Gledacheva V, Todorova M, Kircheva N +10 more

Plain English
This study looked at combining a drug called mebeverine with silver nanoparticles to improve treatment for irritable bowel syndrome (IBS). The researchers found that while the silver nanoparticles reduced inflammation less than mebeverine alone, they still performed better than another common anti-inflammatory drug, diclofenac. This matters because it suggests a new way to safely deliver medications for IBS, potentially leading to more effective treatments in the future. Who this helps: Patients with irritable bowel syndrome.

PubMed

Functionalized Silver Nanoparticles as Multifunctional Agents Against Gut Microbiota Imbalance and Inflammation.

2025

Nanomaterials (Basel, Switzerland)

Stoyanova M, Gledacheva V, Milusheva M, Todorova M, Kircheva N +11 more

Plain English
This study looked at silver nanoparticles loaded with a drug to see if they could fight harmful fungi and reduce inflammation in the gut. The researchers found that these nanoparticles were effective against various fungal strains and harmful bacteria, while also helping to lower inflammation and influence liver cell growth. This matters because these findings could lead to new treatments for gut and liver issues linked to infections and inflammation. Who this helps: This helps patients with gut and liver health problems, as well as doctors looking for new therapies.

PubMed

Correction: Milusheva et al. In Silico, In Vitro, and Ex Vivo Biological Activity of Some Novel Mebeverine Precursors.2023,, 605.

2025

Biomedicines

Milusheva M, Gledacheva V, Stefanova I, Pencheva M, Mihaylova R +5 more

PubMed

Metabolic Profile, Antioxidant, Antimicrobial, Contractile, and Anti-Inflammatory Potential ofLeaves (India).

2025

Life (Basel, Switzerland)

Panova N, Gerasimova A, Tumbarski Y, Ivanov I, Todorova M +8 more

Plain English
Researchers studied Moringa oleifera leaf extracts from India to understand their health benefits. They found that one of the leaf extracts had about twice the amount of amino acids and organic acids compared to the other sample. The extracts showed strong antioxidant properties, with the 50% ethanol extract demonstrating better results than a common anti-inflammatory drug, and it increased muscle contractions in lab tests by up to 134%. Who this helps: This benefits patients seeking natural remedies for inflammation, infections, and digestive issues.

PubMed

Metabolite Signatures and Particle Size as Determinants of Anti-Inflammatory and Gastrointestinal Smooth Muscle Modulation by.

2025

Foods (Basel, Switzerland)

Panova N, Gerasimova A, Todorova M, Pencheva M, Dincheva I +8 more

Plain English
This study examined two different types of microalgae powders to see how their composition and particle size influence their health benefits. The first sample, from India, had finer particles and contained more beneficial compounds like saturated fatty acids, while the second sample, from the UK, had coarser particles and higher levels of unsaturated fatty acids. Overall, the Indian sample showed stronger anti-inflammatory effects and better influences on stomach muscle contraction compared to the UK sample, making it more effective for improving digestive and metabolic health. Who this helps: This research benefits patients seeking better nutritional options for digestive and metabolic issues.

PubMed

Spasmolytic Activity of 1,3-Disubstituted 3,4-Dihydroisoquinolines.

2024

Biomedicines

Milusheva M, Stoyanova M, Gledacheva V, Stefanova I, Todorova M +1 more

Plain English
This study looked at new compounds called 1,3-disubstituted 3,4-dihydroisoquinolines to see if they could help relax smooth muscles, which can be problematic in various health conditions. Researchers found that two of these compounds worked well, similar to a known treatment called mebeverine, indicating they could be useful in treating muscle-related issues. One of these compounds also showed strong antioxidant properties, which is beneficial for reducing cell damage. Who this helps: This benefits patients with muscle disorders and doctors treating those conditions.

PubMed

2-Amino--Phenethylbenzamides for Irritable Bowel Syndrome Treatment.

2024

Molecules (Basel, Switzerland)

Milusheva M, Stoyanova M, Gledacheva V, Stefanova I, Todorova M +5 more

Plain English
This study looked at new drugs for treating irritable bowel syndrome (IBS), a condition that causes stomach pain and discomfort. Researchers created new compounds that helped relax muscles in the gut and showed good anti-inflammatory effects, preventing damage to proteins in cells—better than some existing anti-inflammatory drugs. These findings matter because they could lead to safer and more effective treatments for people suffering from IBS. Who this helps: Patients with irritable bowel syndrome.

PubMed

Therapeutic Potential of 1-(2-Chlorophenyl)-6,7-dimethoxy-3-methyl-3,4-dihydroisoquinoline.

2024

Molecules (Basel, Switzerland)

Slavchev V, Gledacheva V, Pencheva M, Milusheva M, Nikolova S +1 more

Plain English
This study looked at a new compound called DIQ and its effects on muscle contractions in smooth muscle tissue. The researchers found that DIQ reduced the strength of muscle contractions by 47% and affected calcium levels, which are crucial for muscle function, especially when tested alongside certain receptors. This is important because it suggests that DIQ could help manage conditions related to muscle performance and contractions. Who this helps: Patients with muscle-related issues and their doctors.

PubMed

Spasmolytic Activity and Anti-Inflammatory Effect of Novel Mebeverine Derivatives.

2024

Biomedicines

Stoyanova M, Milusheva M, Gledacheva V, Stefanova I, Todorova M +6 more

Plain English
This research focused on developing new versions of a medication called mebeverine, commonly used to treat irritable bowel syndrome (IBS), which causes painful symptoms like cramps and bloating. The study found that these new compounds worked better at relieving muscle spasms compared to traditional mebeverine and also showed strong anti-inflammatory properties. These findings are important because they suggest that these new medications could offer better relief for patients suffering from IBS and related gastrointestinal issues. Who this helps: This helps patients with irritable bowel syndrome and similar digestive problems.

PubMed

In Silico, In Vitro, and Ex Vivo Biological Activity of Some Novel Mebeverine Precursors.

2023

Biomedicines

Milusheva M, Gledacheva V, Stefanova I, Pencheva M, Mihaylova R +5 more

Plain English
This study focused on developing new compounds that could help treat irritable bowel syndrome (IBS), a condition that causes stomach pain and changes in bowel habits. Researchers created and tested several new compounds, discovering that one particular compound, 3-methyl-1-phenylbutan-2-amine, showed significant promise in improving muscle function in the digestive system without harming healthy cells. This is important because it could lead to better, long-lasting treatments for people suffering from IBS. Who this helps: Patients with irritable bowel syndrome.

PubMed

Drug-Delivery Silver Nanoparticles: A New Perspective for Phenindione as an Anticoagulant.

2023

Biomedicines

Nikolova S, Milusheva M, Gledacheva V, Feizi-Dehnayebi M, Kaynarova L +8 more

Plain English
This study looked at how combining a drug called phenindione with silver nanoparticles (tiny particles made of silver) could improve its use as an anticoagulant, which prevents blood from clotting. Researchers found that when phenindione is delivered using these nanoparticles, blood clotting times are about 1.5 times longer than normal, which suggests it could be a safer option than using phenindione alone, which completely halts clotting. This research is important because it may lead to better and safer anticoagulant treatments for patients at risk of blood clots. Who this helps: This helps patients who need anticoagulant therapy, especially those at risk of dangerous blood clots.

PubMed

Synthesis, Molecular Docking, and Biological Evaluation of Novel Anthranilic Acid Hybrid and Its Diamides as Antispasmodics.

2023

International journal of molecular sciences

Milusheva M, Gledacheva V, Stefanova I, Feizi-Dehnayebi M, Mihaylova R +6 more

Plain English
This study focused on creating and testing a new chemical compound, derived from anthranilic acid, to see if it can reduce muscle spasms. The researchers found that this new compound and its formulations effectively relaxed muscles and showed strong antimicrobial and anti-inflammatory properties. Specifically, they demonstrated that these compounds work well against muscle spasms and have potential as new medications for various health issues. Who this helps: Patients suffering from muscle spasms and related conditions.

PubMed

Novel Anthranilic Acid Hybrids-An Alternative Weapon against Inflammatory Diseases.

2023

Pharmaceuticals (Basel, Switzerland)

Milusheva M, Todorova M, Gledacheva V, Stefanova I, Feizi-Dehnayebi M +6 more

Plain English
Researchers studied new types of drugs made from anthranilic acid to find alternatives for existing anti-inflammatory medications, which often have unpleasant side effects. They tested these new compounds and found that some of them were very effective at reducing inflammation, particularly in preventing protein damage, and they also showed promising results in other tests for inhibiting bacteria and muscle spasms. This is important because it could lead to safer and more effective treatments for people suffering from inflammatory diseases. Who this helps: This helps patients with inflammatory conditions who need better medication options.

PubMed

Bioactive Metabolites from the Fruiting Body and Mycelia of Newly-Isolated Oyster Mushroom and Their Effect on Smooth Muscle Contractile Activity.

2022

Foods (Basel, Switzerland)

Brazkova M, Angelova G, Mihaylova D, Stefanova P, Pencheva M +3 more

Plain English
This study looked at a new strain of oyster mushroom to see how its components might benefit human health. Researchers found that the mushroom's fruiting body had a high level of beneficial compounds, with 31.66% of its weight being a type of fiber called β-glucan, and the water extracts showed strong antioxidant activity. Significantly, they discovered that extracts from the mushroom could influence the contractions of stomach muscles, which may have implications for digestive health. Who this helps: This benefits patients with digestive issues and health professionals looking for natural treatments.

PubMed

Impact of a Newly Synthesized Molecule (2-chloro-N-(1-(3,4-dimethoxyphenyl) propan-2-yl)-2-phenylacetamide) on the Bioelectrogenesis and the Contractile Activity of Isolated Smooth Muscles.

2020

Folia medica

Gledacheva VN, Stefanova ID, Slavchev VI, Ardasheva RG, Kristev AD +3 more

Plain English
This study looked at how a new molecule, called IQP, affects the contraction and electrical activity of stomach smooth muscles in rats. Researchers found that IQP relaxes these muscles by blocking calcium from entering the cells and activating a specific signaling pathway, which helps lower the muscle's contraction levels. Specifically, it was noted that IQP changed the activity of the muscles in a way that suggests it could be a useful tool for managing gut muscle movement by causing relaxation. Who this helps: This benefits patients with digestive issues related to muscle contractions, such as those with gastrointestinal disorders.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.